[Federal Register Volume 77, Number 115 (Thursday, June 14, 2012)]
[Notices]
[Page 35689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-14485]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-D-0146]


Guidance for Industry on Irritable Bowel Syndrome--Clinical 
Evaluation of Drugs for Treatment; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of May 31, 2012 (77 FR 32124). 
The document announced the availability of a guidance for industry 
entitled ``Irritable Bowel Syndrome--Clinical Evaluation of Drugs for 
Treatment.'' The document was published with an incorrect docket 
number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy and 
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2012-13143, appearing on page 
32124 in the Federal Register of Thursday, May 31, 2012, the following 
correction is made:
    1. On page 32124, in the first column, in the headings section of 
the document, ``[Docket No. FDA-2012-D-0146]'' is corrected to read 
``[Docket No. FDA-2010-D-0146]''.

    Dated: June 8, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-14485 Filed 6-13-12; 8:45 am]
BILLING CODE 4160-01-P